These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6512917

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Disposition and tolerance of suxibuzone in horses.
    Jaraiz MV, Rodriguez C, San Andres MD, Gonzalez F, San Andres MI.
    Equine Vet J; 1999 Sep; 31(5):411-6. PubMed ID: 10505957
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats.
    Cheng Z, Welsh E, Nolan A, McKellar QA.
    Vet Rec; 1997 Jan 11; 140(2):40-3. PubMed ID: 9123796
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [The concentration changes of different phenylbutazone formulations in horse plasma].
    Keller H, Hashem A.
    Dtsch Tierarztl Wochenschr; 1996 Jun 11; 103(6):224-30. PubMed ID: 8766906
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics of methocarbamol and phenylbutazone in exercised Thoroughbred horses.
    Knych HK, Stanley SD, Seminoff KN, McKemie DS, Kass PH.
    J Vet Pharmacol Ther; 2016 Oct 11; 39(5):469-77. PubMed ID: 26924025
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetics of phenylbutazone in two age groups of ponies: a preliminary study.
    Lees P, Maitho TE, Taylor JB.
    Vet Rec; 1985 Mar 02; 116(9):229-32. PubMed ID: 4002593
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Simultaneous determination of phenylbutazone and its metabolites in plasma and urine by high-performance liquid chromatography.
    Marunaka T, Shibata T, Minami Y, Umeno Y.
    J Chromatogr; 1980 Sep 12; 183(3):331-8. PubMed ID: 7419650
    [Abstract] [Full Text] [Related]

  • 35. Effect of an endurance-like exercise on the disposition and detection time of phenylbutazone and dexamethasone in the horse: application to medication control.
    Authie EC, Garcia P, Popot MA, Toutain PL, Doucet M.
    Equine Vet J; 2010 Apr 12; 42(3):240-7. PubMed ID: 20486981
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Determination of bumadizone, phenylbutazone and oxyphenbutazone in human plasma by high-performance liquid chromatography (author's transl)].
    Spahn H, Mutschler E.
    Arzneimittelforschung; 1981 Apr 12; 31(3):495-9. PubMed ID: 6894379
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Direct injection HPLC method for the determination of phenylbutazone and oxyphenylbutazone in serum using a semipermeable surface column.
    Haque A, Stewart JT.
    J Pharm Biomed Anal; 1997 Oct 12; 16(2):287-93. PubMed ID: 9408846
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.